GlassScriptPhysician profile
Melissa H Warta
NPI 1083660278
$969.42
in general payments reported to CMS, 2019-2025
8 companies · $27.41 in 2025
The $27.41 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.10 · 2020: $239 · 2021: $81.47 · 2022: $158 · 2023: $410 · 2024: $17.49 · 2025: $27.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $454.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $487.05 | 2020-2023 | Advantagerib |
| Integra Lifesciences Corporation | $282.34 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Atricure, INC. | $75.58 | 2021-2023 | |
| Smith+Nephew, INC. | $41.30 | 2019-2021 | |
| Tela Bio, INC. | $27.41 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Baxter Healthcare | $24.41 | 2021 | |
| Polarityte, INC. | $17.41 | 2020 | |
| Avanos Medical | $13.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Warta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.